Half Year 2021 ReNeuron Group PLC Earnings Call Transcript
Good morning, everyone, and a very happy new year to everyone. Thanks for attending this analyst meeting. I'm Olav Hellebo, CEO; and as mentioned, Michael Hunt, our Chief Financial Officer, is on the call as well.
Before we begin the presentation, just want to make sure everyone either has today's slides in front of them or know how to get them. A copy has been e-mailed to you. If you haven't received it, then you can go to the Investors section of our website and pick them down there. So let's, with that, jump into the presentation that I hope you're looking at. Page 2 has the disclaimer. So I'll leave that for your perusal.
On Page 3, we can go to the Board members and some selected members of the management team. What I wanted to focus on, on that page actually is the worldwide experts in cell and gene therapy for ophthalmology that we're working with. We have the best of the best when it comes to getting advice in our program here. Dr. Jason Comander is at Mass Eye and Ear, which is part of Harvard. And he has treated -- he is
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |